| Name | pagibaximab |
|---|
| Description | Pagibaximab is a chimeric IgG1 antibody recognizing the surface component lipoteichoic acid of S. aureus and S. epidermidis. Pagibaximab can be used to prevent staphylococcal sepsis[1]. |
|---|---|
| Related Catalog | |
| Target |
S. epidermidis lipoteichoic acid[1] |
| References |
| No Any Chemical & Physical Properties |